Immune

Autoimmune hepatitis type 1

ORPHA:563576 ↗Clinical subtype

1

studies recruiting now

as of 7 Sept 2026

6

studies registered in total

as of 7 Sept 2026

1

countries with a recruiting site

as of 7 Sept 2026

26 May 2021

most recent study posted

among recruiting studies

Recruiting trials

Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.

Search all Autoimmune hepatitis type 1 studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Autoimmune hepatitis type 1 study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Autoimmune hepatitis type 1

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Treatments being studied

13 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 3Phosphatidylcholine
Phase 3Cyclosporine (Capimune)
Phase 2/3Ianalumab
Phase 2/3Prednisone (Cortan)
Phase 2/3Budesonide (Aircort)
Phase 2Belimumab (Benlysta)
Phase 2Preimplantation Factor
Phase 2Zetomipzomib

+ 5 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).